EIR AstraZeneca Pharmaceuticals LP Mar 2010

Mike Rashti FDA$595.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Wilmington, DE, United States facility and issued inspectional observation (via FDA 483) on 31 Mar 2010.

Product details

  • Category:
  • Inspection end: 31 Mar 2010
  • Location: Wilmington, United States
  • FEI: 2518137
Add To Cart